Literature DB >> 33387338

Clinical significance of glomerular C3 deposition in primary membranous nephropathy.

Halil Yazici1, Yasar Caliskan2,3, Ozgur Akin Oto1, Erol Demir1, Safak Mirioglu1, Ahmet Burak Dirim1, Yasemin Ozluk4, Egemen Cebeci5, Taner Basturk6, Ali Riza Ucar1, Lala Soltanova1, Kanan Nuriyev1, Isin Kilicaslan4.   

Abstract

BACKGROUND: We aimed to investigate the effects of glomerular C3 deposition on clinical, histopathological features, and outcomes of patients with primary membranous nephropathy (MN).
METHODS: A total of 261 patients with biopsy-proven primary MN, who were on follow up for at least 6 months, were included in the study. The patients were grouped according to their C3 immunostaining in kidney biopsy samples at the time of diagnosis: Low intensity [LI; (C3 1 +)] and high intensity [HI; (C3 2 + or C3 3 +)]. The primary outcome was the development of kidney failure. Complete (CR) or partial remission (PR) was defined as secondary outcome.
RESULTS: Sixteen patients reached the primary outcome after a median follow-up of 33.8 months. Patients in the high intensity group (119 cases) had lower eGFR and higher proteinuria at admission and last follow-up compared to patients in the low intensity group (142 cases). Also, more patients in the high intensity group reached the primary outcome compared to patients in the low intensity group: twelve patients (10.1%) in the high intensity group and four patients (2.8%) in the low intensity group reached the primary outcome (p = 0.015). Kaplan-Meier analysis demonstrated that patients in the high intensity group had a higher risk for kidney failure (p = 0.02). In multivariate logistic regression analysis, high intensity C3 deposition and initial estimated glomerular filtration rate (eGFR) indepenently predicted primary outcome.
CONCLUSION: Extensive glomerular C3 deposition is a predictor of kidney failure in patients with MN.

Entities:  

Keywords:  C3; Complement system; Kidney failure; Membranous nephropathy

Year:  2021        PMID: 33387338     DOI: 10.1007/s40620-020-00915-w

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  3 in total

1.  Analysis of 260 cases of membranous glomerulonephritis in renal biopsy material.

Authors:  E Beregi; I Varga
Journal:  Clin Nephrol       Date:  1974 Nov-Dec       Impact factor: 0.975

2.  The clinical course of idiopathic membranous nephropathy.

Authors:  D T Erwin; J V Donadio; K E Holley
Journal:  Mayo Clin Proc       Date:  1973-10       Impact factor: 7.616

3.  The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.

Authors:  A M Davison; J S Cameron; D N Kerr; C S Ogg; R W Wilkinson
Journal:  Clin Nephrol       Date:  1984-08       Impact factor: 0.975

  3 in total
  3 in total

1.  Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy.

Authors:  Xing Chen; Shuchun Chen; Zelin Li; Xiaoyu Pan; Yujiao Jia; Zhijuan Hu; Kai Niu; Bing Liu; Qingjuan Ren
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

Review 2.  Primary membranous nephropathy: an endless story.

Authors:  Ponticelli Claudio
Journal:  J Nephrol       Date:  2022-10-17       Impact factor: 4.393

Review 3.  Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.

Authors:  Hua Miao; Yamei Zhang; Xiaoyong Yu; Liang Zou; Yingyong Zhao
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.